Wednesday August 19, 2026
Section

Time Sensitive

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
Press Release

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

Revenue for the first half of 2026 increased 29% year-over-year to US$44.5 million (RMB302.2 million), primarily

Read Full Story